In glioblastoma cancer stem cells (GBM CSCs), Ascl1 has been shown to bind a site near the Wnt antagonist gene Dkk1, whose regulation mediates Ascl1 activity in these cells (Rheinbay et al., 2013). Here, ASCL1 is linked to glioblastoma.